Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Renovorx Inc (RNXT)

Renovorx Inc (RNXT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
RenovoRx CEO Shaun Bagai to Present at iAccess Alpha Virtual Best Ideas Winter Investment Conference 2025 on December 9th GlobeNewswire - Mon Dec 1, 7:30AM CST

MOUNTAIN VIEW, Calif., Dec. 01, 2025 (GLOBE NEWSWIRE) -- RenovoRx, Inc. (Nasdaq: RNXT)  (“RenovoRx” or “the Company”), a life sciences company developing innovative targeted oncology therapies...

RNXT : 0.9500 (+5.04%)
iAccess Alpha's Virtual Best Ideas Winter Investment Conference December 9-10, 2025 ACCESS Newswire - Mon Dec 1, 3:00AM CST

RALEIGH, NC / ACCESS Newswire / December 1, 2025 / iAccess Alpha's Virtual Best Ideas Winter Investment Conference will take place on December 9-10, 2025, bringing together top micro-cap companies and...

MOB : 7.43 (+1.78%)
BOSC : 4.85 (+5.21%)
STRT : 79.23 (-0.79%)
ELWT : 6.79 (+2.11%)
DGX.VN : 5.300 (+11.58%)
BCHT.TO : 1.20 (-2.44%)
GAME : 0.5087 (+4.16%)
ACNT : 15.06 (-0.66%)
WYY : 6.69 (-1.91%)
DCGO : 1.0500 (-2.78%)
DGXX : 3.78 (+11.34%)
SCNX : 0.6061 (-0.38%)
RenovoRx CEO Shaun Bagai to Present at the Alliance Global Partners Emerging AgBiotech/Bio-Solutions Virtual Showcase on November 20th GlobeNewswire - Wed Nov 19, 7:30AM CST

MOUNTAIN VIEW, Calif., Nov. 19, 2025 (GLOBE NEWSWIRE) -- RenovoRx, Inc. (Nasdaq: RNXT)  (“RenovoRx” or “the Company”), a life sciences company developing innovative targeted oncology therapies...

RNXT : 0.9500 (+5.04%)
RenovoRx Reports Third Quarter 2025 Financial Results, Including Approximately $900,000 in Year-to-Date Revenue, and Provides Business Update GlobeNewswire - Thu Nov 13, 3:05PM CST

September 30, 2025 Cash and Cash Equivalents at $10 million Revenue Expected to Grow in 2026 and Continue to Offset Cash Burn Management to Host Conference Call Today at 4:30 p.m. ET MOUNTAIN...

RNXT : 0.9500 (+5.04%)
RenovoRx CEO Shaun Bagai to Participate at the Canaccord Genuity MedTech, Diagnostics & Digital Health & Services Forum on November 20th GlobeNewswire - Tue Nov 4, 7:30AM CST

MOUNTAIN VIEW, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- RenovoRx, Inc . (“RenovoRx” or the “Company”) (Nasdaq: RNXT) , a life-sciences company developing innovative targeted oncology therapies...

RNXT : 0.9500 (+5.04%)
RenovoRx to Host Third Quarter 2025 Financial Results and Business Highlights Conference Call on November 13th at 4:30 p.m. ET GlobeNewswire - Mon Oct 27, 7:30AM CDT

MOUNTAIN VIEW, Calif., Oct. 27, 2025 (GLOBE NEWSWIRE) -- RenovoRx, Inc. (“RenovoRx” or the “Company”) (Nasdaq: RNXT) , a life sciences company developing innovative targeted oncology therapies...

RNXT : 0.9500 (+5.04%)
RenovoRx to Host Third Quarter 2025 Financial Results and Business Highlights Conference Call on November 13th at 4:30 p.m. ET GlobeNewswire - Mon Oct 27, 7:30AM CDT

MOUNTAIN VIEW, Calif., Oct. 27, 2025 (GLOBE NEWSWIRE) -- RenovoRx, Inc. (“RenovoRx” or the “Company”) (Nasdaq: RNXT) , a life sciences company developing innovative targeted oncology therapies...

RNXT : 0.9500 (+5.04%)
RenovoRx Expands Scientific Advisory Board with Internationally Renowned Interventional Oncologist, Thierry de Baère, MD, PhD GlobeNewswire - Thu Oct 9, 7:30AM CDT

LOS ALTOS, Calif., Oct. 09, 2025 (GLOBE NEWSWIRE) -- RenovoRx, Inc . (“RenovoRx” or the “Company”) (Nasdaq: RNXT) , a life sciences company developing innovative targeted oncology therapies...

RNXT : 0.9500 (+5.04%)
RenovoRx’s PanTheR Post-Marketing Registry Study Progresses with First Clinical Procedure and Addition of Two Participating Clinical Sites GlobeNewswire - Thu Sep 25, 7:30AM CDT

First Registry-Eligible Patient Procedure Commenced at the University of Vermont Cancer Center Baptist Health Miami Cancer Institute and University of Pittsburgh Medical Center Join the University...

RNXT : 0.9500 (+5.04%)
Updated Lineup Announced for iAccess Alpha's Virtual Best Ideas Fall Investment Conference September 16-17, 2025 ACCESS Newswire - Tue Sep 16, 3:00AM CDT

iAccess Alpha's Virtual Best Ideas Fall Investment Conference September 16-17, 2025

SKYH : 9.71 (-0.82%)
XTRA.TO : 0.60 (-4.76%)
CJMB : 1.4700 (+5.00%)
XTRAF : 0.4355 (-3.22%)
PMNT : 0.4610 (+1.47%)
TOMZ : 0.8000 (+1.92%)
SKYX : 2.44 (+6.55%)
HIT : 1.2700 (-1.55%)
NNBR : 1.2700 (unch)
AENT : 6.83 (-0.87%)
ACNT : 15.06 (-0.66%)
PRSO : 0.9452 (-1.85%)

Barchart Exclusives

Michael Burry Doubles Down on Molina Healthcare Stock. What Is the Bull Case for MOH Here? Barchart - 21 minutes ago
Burry finds value in holding this healthcare counter for the long term. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot